Curtis Health Caps (CHC): Offering Trusted and Comprehensive CDMO Services in the Pharmaceutical Industry

Anna Michalak, PhD, Board Member, Chief Product Development and Quality Officer, Curtis Health Caps (CHC)
Anna Michalak, PhD, Board Member, Chief Product Development and Quality OfficerIn the recent times, the manufacturing industry has been facing unprecedented challenges. Business leaders have met a series of successive crises such as that of COVID-19, the war in Ukraine, and the risks of a recession. Simultaneously, increasing labor costs, growing energy, and commodity prices, and supply chain issues have driven inflation much higher than expected. As a result, contract development and manufacturing organizations (CDMOs) are getting squeezed by a massive rise in input cost: raw materials, production support materials, as well as all professional services.

A CDMO specializing in soft gelatin capsules and non-sterile liquid products, Curtis Health Caps (CHC) successfully overcomes these challenges by implementing the right strategies in the purchasing strategies, cost optimizations, production improvements, flexible cooperation with clients and business partners. They have signed long-term contracts with suppliers of energy and raw materials and try to diversify suppliers, anticipate customer orders, and shorten lead time.

With over three decades of presence in international markets, CHC has been recognized as a trusted GMP Certified partner providing services to clients from the pharmaceutical, food, and cosmetics industries as producers of food supplements, medicinal products, medical devices, cosmetics, and veterinary products. The company offers a comprehensive range of solutions—from R&D services and regulatory audits to quality consultancy, production, storage, and transport, all carefully tailored to the market’s ever-changing needs, while the account manager guides the client through the whole process. With current supply-chain disruptions in the pharmaceutical market, CHC offers its clients the alternative to transfer manufacturing and secure patient access to products.
In addition, CHC will continue to strive for even greater efficiency and competitiveness. They plan to extend the offer with activities related to creating an attractive brand for the client’s product line and its further development, including target market analysis and strategy building. CHC operate a modern and innovative machinery park in Poland that features a well-equipped R&D department, employing experts across a range of fields.

“As a CDMO, with over 30 years of presence in international markets, we provide clients with high-quality service throughout the whole product development process, from initial concept to final product,” says Anna Michalak, Ph.D., Board Member, and Chief Product Development and Quality Officer, at CHC.

CHC provides clients with high-quality service throughout the whole product development process. The company’s flexibility, knowledge of market trends, and willingness to support clients with expertise at every stage of the process help them deliver according to the diverse expectations of clients.

As a CDMO, with over 30 years of presence in international markets, we provide clients with high-quality service throughout the whole product development process, from initial concept to final product

Clients approach CHC with the need for a new product, and the company’s experienced team takes care of the entire development and production. In addition, the client-centric approach, along with the comprehensive solution portfolio, has enabled the company to work with a wide range of clients, including both large pharmaceutical companies and startups.

For instance, for a client facing lack of flexibility in the face of recent problems with disrupted supply chains and wanted to produce vitamin D3 in very large quantities in an extremely short time, CHC was able to deliver the product quickly. The company managed to succeed and meet the client’s expectations in a short time due to its flexibility, cooperation between various departments, expertise in D3 products, perfect cooperation with raw material suppliers, and production tests which were conducted with extraordinary speed.

Since the beginning, CHC has offered a wide range of vitamin D products in various forms: soft capsules, chewable capsules, twist-off capsules, drops, sprays, and liquid vitamin D products suitable for vegans and vegetarians in the dietary supplement category. The company has invested in the development of medicinal products with this active substance and offers a finished drug dossier that meets the legal requirements for the registration of medicinal products in the EU. In addition to vitamin D, the company’s R&D Division has started work on the development of further medicinal products, details to follow shortly. Going forward, as company with an international reach, CHC plans to continue to expand geographically and extend its offering to serve clients with more efficiency.